The increasing research in protein engineering and rising government funding for new drug discovery are expected to be some major drivers for the market.
Market Size – USD 1.86 Billion in 2019, Market Growth – CAGR of 12.3%, Market Trends– The growing research institutions across developing economies is expected to fuel the market in the forecast period.
According to the current analysis of Reports and Data, the Protein Engineering market was valued at USD 1.86 billion in 2019 and is expected to reach USD 4.77 billion by the year 2027, at a CAGR of 12.3%. Protein engineering is the process of conception and production of unnatural polypeptides, which is achieved through the modification of different amino acid sequences that are found in nature. With the wide application of protein engineering, various synthetic protein structures and functions can now be designed completely using a computer and produced in the laboratory using various methods.
With the advent of technology, the rising demand is expected to provide traction to the market. For instance, Computational protein design holds a potential promise to revolutionize protein engineering. Protein engineering is significantly in demand as it can develop useful or valuable proteins. It is known to be an emerging research field that helps researchers in understanding the protein folding and recognition used for protein design principles. Protein engineering market is triggered owing to various reasons such as availability of immense information regarding 3D protein structure, advancement in structural bioinformatics, novel protein design algorithms, and other factors that have made it successfully possible to use computational approaches for research and development in protein engineering. Strategic utilization of approaches that have been discovered with research has enabled better stability and increased catalytic activity of the protein. Moreover, it has increased its applicability in various fields that will further expand the market. Protein engineering has also evolved to become a potent tool contributing considerably to the developments in both synthetic biology and metabolic engineering. The rising funding for synthetic biology by the government and other healthcare institutions may drive the industry extensively in the future. Furthermore, the substantial ongoing research in the drug discovery process that finds treatments and cure for various diseases in nature is expected to fuel the market widely in the forecast period. The growing technological advancements and innovative instruments useful for protein engineering may drive the market extensively in the future. Also, the emergence of new diseases due to microorganisms may also trigger the market widely in the future.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3369
The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.
Key companies operating in the market and profiled in the report include:
Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, GE Healthcare, Waters Corporation, Sigma-Aldrich Corporation, Genscripts USA, Inc. and Perkinelmer, Inc.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3369
The Protein Engineering market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.
Segments Covered in the report
By Product Outlook (Revenue in Million USD; 2017-2027)
- Instruments
- Consumables
- Software & Services
By Type Outlook (Revenue in Million USD; 2017-2027)
- Monoclonal Antibodies
- Erythropoietin
- Interferons
- Vaccines
- Colony-stimulating Factors
- Growth Hormones
- Coagulation Factors
- Others
By Technology Outlook (Revenue in Million USD; 2017–2027)
- Rational Protein Design
- Irrational Protein Design
By End Use Outlook (Revenue in Million USD; 2017–2027)
- Biopharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
Key Regions Analyzed in the Report include:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/protein-engineering-market
Furthermore, it consists information about individual segment of the Protein Engineering market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.
Further key findings from the report suggest
- Innovations in the protein engineering industry has contributed to the high growth of the industry. For instance, in March 2020, scientists from the Unites States and Taiwan introduced a new protein based on the sonification which was made using machine learning technique.
- In 2019, creative Biolabs launched a new product into the industry known as cd25 monoclonal antibody. The antibody can be widely used in conditions like rejection by the body in organ transplantation significantly kidney transplants.
- Various collaborations are expected to fuel the industry growth and is known to have anticipated the market growth. For instance, in 2019, Agilent Technologies acquired BioTek Instruments. The merger allowed Agilent to establish itself in the immunotherapy and immune-oncology segments and strengthen its position.
- In March 2020, Gilead announced its acquisition with Forty-Seven for around 4.9 billion USD. The acquisition, would particularly help Gilead to expand itself in the immuno-oncology department.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3369
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
Browse More Reports:
Purified Human Proteins Market
ReportCrux Market Research has published a new report titled “Autonomous Vehicle Market by Component (Hardware, Software, and Services); by Level of Automation (Level 1, Level 2 & 3, Level 4, and Level 5); by Type (Conventional, Hybrid Vehicle, and Electric Vehicle); by Application (Transportation [Industrial, and Commercial], and Defense); and by Region: Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027”.
Autonomous Vehicle Market SizeAccording to the report, global demand for autonomous vehicle market was valued at approximately USD 13.62 Billion in 2019 and is expected to generate revenue of around USD 142.41 Billion by end of 2027, growing at a CAGR of around 34.1% between 2020 and 2027.Market Overview:Autonomous vehicle or self-driving car or driverless car is a modern car design capable of sensing and reading the environment, and working without human intervention.
All prototypes are currently being tested in various automobile companies, universities research centers.
Other benefits like decreased risk of collisions, improved protection, and increased road ability are contributing significantly to these vehicles since its introduction in the market.Growing safety concerns and advances in automotive technology have led the governments of countries like Germany, U.S., China, and Japan to accept and penetrate autonomous vehicles, among others.
Compared with other segments, its contribution will be the largest.Level of automation type segment accounted for almost 70% share of the Autonomous Vehicle Market in 2019Based on level of automation, the market is categorized into Level 2 & 3, Level 4, Level 1, and Level 5.
The lack of electric vehicle infrastructure in developing countries also supports demand for the ICE vehicles market.
The report covers detailed Vodka Market analysis by Product, Application, Region, Major Player, Market Size, Share, Trends, Growth and Forecast 2018-2025.Get FREE Exclusive PDF Sample Copy of This Report @ https://www.upmarketresearch.com/home/requested_sample/7749The Vodka Market report published on Up Market Research is spread across 101 pages and provides an overview of the 2018 – 2025 of Vodka Market Research Report by Product Type, End-User / Application and Regions / Countries.
The Global Vodka Market is projected to grow at a healthy growth rate from 2018 to 2025 according to new research.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.Vodka Market Analysis Report provides an overview of the various factors enabling growth in the market.
It also presents insights into various restraints that pose threat and highlights opportunities that will help the market pick pace in the forthcoming years.
The report compiles exhaustive information obtained via proven research methodologies and from trusted sources from within the industries.
It also includes expert opinions to provide readers a clearer perspective regarding the global market.
Active Pharmaceutical Ingredients Market to grow by $ 64.53billion|Key Drivers and Trends|TechnavioAccording to Technavio, the active pharmaceutical ingredients market size is expected to value at $ 64.53 billion during 2021-2025.
The market sizing analysis in the report reveals that the market growth will progressing at a CAGR of over 6.10%.
The report offers exclusive detailed COVID-19 impact study, which majorly highlights vendor performance and new business opportunities during and post pandemic period.View our exclusive report on the CMOS image sensors market covering market trends, vendor analysis, and growth opportunities to improve your business - Download Free Sample Report.Active Pharmaceutical Ingredients Market Trends & DriversThe active pharmaceutical ingredients market research report has a detailed analysis on the key drivers, trends, and challenges, which will help vendors in making important business decisions and modifications to cater to the changing consumer demand.
While it is essential to capitalize on key drivers such as evolving api manufacturing scenario in developing countries, it is also crucial to understand the challenges that will impede sales during the forecast period.
Identifying and addressing market growth challenges will create additional opportunities for the existing and new market players.
Know more about COVID-19 Crisis and Recovery Analysis?
